ABCC7 p.Ala204Thr
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 19017867
[PubMed]
Mutesa L et al: "Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants."
No.
Sentence
Comment
25
Cell Transfection HeLa cells (7.105 cells per 100-mm dish) were transfected with 5 g of pcDNA3, wild-type (wt)-CFTR, F508del, or A204T plasmid (Transfectin; Bio-Rad Laboratories; Gent, Belgium).
X
ABCC7 p.Ala204Thr 19017867:25:137
status: NEW63 A 4-year-old girl (patient P041) with mild pulmonary disease associated with severe PEM status and a positive sweat chloride concentration (113 mmol/L) had a novel GϾA mutation at nucleotide position 742 (Fig 1, 2 left, A), substituting a threonine for an alanine at amino acid position 204 (p.A204T).
X
ABCC7 p.Ala204Thr 19017867:63:20
status: NEWX
ABCC7 p.Ala204Thr 19017867:63:245
status: NEWX
ABCC7 p.Ala204Thr 19017867:63:300
status: NEW103 Left, A: the electrophoregram shows the wt and A204T DNA sequence analyses of exon 6a.
X
ABCC7 p.Ala204Thr 19017867:103:47
status: NEW109 Bottom right, C: Western blotting analysis of HeLa cells transiently expressing CFTR-wt, F508del, or A204T.
X
ABCC7 p.Ala204Thr 19017867:109:28
status: NEWX
ABCC7 p.Ala204Thr 19017867:109:101
status: NEW9 Results: Three CFTR mutants, including one previously undescribed missense mutation (p.A204T), and a 5T/7T variant were identified in five patients.
X
ABCC7 p.Ala204Thr 19017867:9:87
status: NEW23 Site-Directed Mutagenesis and Expression of CFTR Mutant The p.A204T mutation was introduced in the pcDNA3-CFTR expression plasmid (QuikChange XL Site-Directed Mutagenesis kit; Stratagene; La Jolla, CA).
X
ABCC7 p.Ala204Thr 19017867:23:62
status: NEW51 We found 14 CFTR variants (Table 2), as follows: two known mutations (p.F693L and c.3120 ϩ 1GϾA); a novel p.A204T missense mutation; and nine sequence polymorphisms; and two previously uncharacterized intronic nucleotide changes, c.3272-32T Ͼ C in the intron 17a and c.4575 ϩ 2GϾA in the 3Ј-untranslated region (UTR).
X
ABCC7 p.Ala204Thr 19017867:51:120
status: NEW61 The p.F693L mutation was identified in the following two patients: a 13-year-old boy (patient P004) with recurrent respiratory infections, lung colonization by P aeruginosa, GI symptoms, failure to thrive, Table 1-Characteristics of 60 Patients With CF-Like Symptoms Variables Patients (n ϭ 60) % Age, yr Range 2-14 Mean Ϯ SD 5.8 Ϯ 1.7 Sex Male 33 55 Female 27 45 Phenotype Chronic lung disease 39 65 GI symptoms 41 68 Pancreatic insufficiency 19 32 Failure to thrive 23 38 PEM 52 87 Diabetes mellitus 4 7 Nasal polyps 3 5 Sweat chloride test results Positive (Ͼ 60 mmol/L) 37 62 Borderline (40-60 mol/L) 11 18 Normal (Ͻ 40 mmol/L) 9 15 Test not performed 3 5 www.chestjournal.org CHEST / 135 / 5 / MAY, 2009 1235 (c) 2009 American College of Chest Physicians at University of North Carolina on August 8, diabetes mellitus, and PEM; and a 9-year-old girl (patient P038) with mild pulmonary symptoms, GI symptoms, and severe PEM.
X
ABCC7 p.Ala204Thr 19017867:61:79
status: NEWX
ABCC7 p.Ala204Thr 19017867:61:138
status: NEW65 To investigate its causative role in the CF phenotype, the expression of the p.A204T CFTR was studied after transient transfection of a p.A204T-CFTR-pcDNA3 expression vector in HeLa cells.
X
ABCC7 p.Ala204Thr 19017867:65:79
status: NEWX
ABCC7 p.Ala204Thr 19017867:65:138
status: NEW67 Expression of the p.A204T CFTR allowed the expression of the mature glycosylated CFTR isoform at a level higher than that observed with the p.F508del mutant but reproducibly lower than the wt-CFTR level.
X
ABCC7 p.Ala204Thr 19017867:67:20
status: NEW75 The silent polymorphism p.T577T was found in a patient with a p.F693L CFTR mutation, whereas the c.72TϾC was detected in the patient with the novel p.A204T CFTR mutation.
X
ABCC7 p.Ala204Thr 19017867:75:156
status: NEW91 Table 3-Comparison of Clinical Findings in Five Patients With Identified CFTR and ENaC Mutants* Patient/Sex/Age, yr Phenotype Sweat Test Value, mmol/L CFTR Genotype (͓TG͔mTn) Genotype ENaC Genotype (␣, beta, and ␥ Subunits) P004/M/13 LD, PA, GI, PEM 94 p.F693L/- (TG)10T7/(TG)11T9 p.V348M (beta) p.S212S† (␥) P038/F/9 LD, SA, GI, PEM 124 p.F693L/- (TG)10T7/(TG)10T9 p.T577T (beta) p.G442V† (beta) P007/F/7 LD, PA, GI, PEM 85 c.3120 ϩ 1GϾA/- (TG)11T7/(TG)12T7 p.V573I (␣) p.G442V† (beta) P029/M/2 GI, PI, FT, PEM 77 c.4575 ϩ 2GϾA‡/- (TG)10T7/(TG)11T5 c.1473 ϩ 28CϾT (beta) c.1176 ϩ 30GϾC (␥) P041/F/4 LD, PEM 113 p.A204T/- (TG)10T7/(TG)10T7 c.72 TϾC (␣ 5Ј UTR) p.G442V† (beta) *Tn ϭ poly-T tract; TGm ϭ poly-TG loci; LD ϭ lung disease; PA ϭ P aeruginosa lung colonization; FT ϭ failure to thrive; DM ϭ diabetes mellitus; PI ϭ pancreatic insufficiency; SA ϭ Staphylococcus aureus lung colonization; F ϭ female; M ϭ male.
X
ABCC7 p.Ala204Thr 19017867:91:737
status: NEW101 The identified mutations were as follows: (1) a c.3120 ϩ 1GϾA CFTR mutation, frequently observed in African patients and responsible for a splicing defect4; and (2) a p.F693L CFTR missense mutation in two patients with CF-like severe symptoms including recurrent lung disease (the same amino acid change at the same residue has been previously reported23 in an Italian CF patient with severe symptoms; moreover, these two patients carried SCNN1B mutations) [Table 3]; (3) a TG11T5 variant, which can be associated with mild CF signs; and (4) a novel p.A204T CFTR mutation.
X
ABCC7 p.Ala204Thr 19017867:101:564
status: NEW102 This 204 residue is in the first membrane-spanning domain (MSD1), and almost all of the mutations within this region are associated with a mild phenotype, as was observed in our patient.24,25 This missense mutation Figure 2. p.A204T missense mutation in the CFTR gene.
X
ABCC7 p.Ala204Thr 19017867:102:227
status: NEW113 Exogenous expression of a p.A204T-CFTR protein in cells led to a weak expression and an altered protein glycosylation, but functional studies are required in order to assess precisely the consequences of this variant.
X
ABCC7 p.Ala204Thr 19017867:113:28
status: NEW5 Results: Three CFTR mutants, including one previously undescribed missense mutation (p.A204T), and a 5T/7T variant were identified in five patients.
X
ABCC7 p.Ala204Thr 19017867:5:87
status: NEW19 Site-Directed Mutagenesis and Expression of CFTR Mutant The p.A204T mutation was introduced in the pcDNA3-CFTR expression plasmid (QuikChange XL Site-Directed Mutagenesis kit; Stratagene; La Jolla, CA).
X
ABCC7 p.Ala204Thr 19017867:19:62
status: NEW21 Cell Transfection HeLa cells (7.105 cells per 100-mm dish) were transfected with 5 g of pcDNA3, wild-type (wt)-CFTR, F508del, or A204T plasmid (Transfectin; Bio-Rad Laboratories; Gent, Belgium).
X
ABCC7 p.Ala204Thr 19017867:21:137
status: NEW47 We found 14 CFTR variants (Table 2), as follows: two known mutations (p.F693L and c.3120 ϩ 1GϾA); a novel p.A204T missense mutation; and nine sequence polymorphisms; and two previously uncharacterized intronic nucleotide changes, c.3272-32T Ͼ C in the intron 17a and c.4575 ϩ 2GϾA in the 3Ј-untranslated region (UTR).
X
ABCC7 p.Ala204Thr 19017867:47:120
status: NEW59 A 4-year-old girl (patient P041) with mild pulmonary disease associated with severe PEM status and a positive sweat chloride concentration (113 mmol/L) had a novel GϾA mutation at nucleotide position 742 (Fig 1, 2 left, A), substituting a threonine for an alanine at amino acid position 204 (p.A204T).
X
ABCC7 p.Ala204Thr 19017867:59:245
status: NEWX
ABCC7 p.Ala204Thr 19017867:59:300
status: NEW71 The silent polymorphism p.T577T was found in a patient with a p.F693L CFTR mutation, whereas the c.72TϾC was detected in the patient with the novel p.A204T CFTR mutation.
X
ABCC7 p.Ala204Thr 19017867:71:156
status: NEW87 Table 3-Comparison of Clinical Findings in Five Patients With Identified CFTR and ENaC Mutants* Patient/Sex/Age, yr Phenotype Sweat Test Value, mmol/L CFTR Genotype (͓TG͔mTn) Genotype ENaC Genotype (␣, beta, and ␥ Subunits) P004/M/13 LD, PA, GI, PEM 94 p.F693L/- (TG)10T7/(TG)11T9 p.V348M (beta) p.S212S† (␥) P038/F/9 LD, SA, GI, PEM 124 p.F693L/- (TG)10T7/(TG)10T9 p.T577T (beta) p.G442V† (beta) P007/F/7 LD, PA, GI, PEM 85 c.3120 ϩ 1GϾA/- (TG)11T7/(TG)12T7 p.V573I (␣) p.G442V† (beta) P029/M/2 GI, PI, FT, PEM 77 c.4575 ϩ 2GϾA‡/- (TG)10T7/(TG)11T5 c.1473 ϩ 28CϾT (beta) c.1176 ϩ 30GϾC (␥) P041/F/4 LD, PEM 113 p.A204T/- (TG)10T7/(TG)10T7 c.72 TϾC (␣ 5Ј UTR) p.G442V† (beta) *Tn ϭ poly-T tract; TGm ϭ poly-TG loci; LD ϭ lung disease; PA ϭ P aeruginosa lung colonization; FT ϭ failure to thrive; DM ϭ diabetes mellitus; PI ϭ pancreatic insufficiency; SA ϭ Staphylococcus aureus lung colonization; F ϭ female; M ϭ male.
X
ABCC7 p.Ala204Thr 19017867:87:737
status: NEW97 The identified mutations were as follows: (1) a c.3120 ϩ 1GϾA CFTR mutation, frequently observed in African patients and responsible for a splicing defect4; and (2) a p.F693L CFTR missense mutation in two patients with CF-like severe symptoms including recurrent lung disease (the same amino acid change at the same residue has been previously reported23 in an Italian CF patient with severe symptoms; moreover, these two patients carried SCNN1B mutations) [Table 3]; (3) a TG11T5 variant, which can be associated with mild CF signs; and (4) a novel p.A204T CFTR mutation.
X
ABCC7 p.Ala204Thr 19017867:97:564
status: NEW98 This 204 residue is in the first membrane-spanning domain (MSD1), and almost all of the mutations within this region are associated with a mild phenotype, as was observed in our patient.24,25 This missense mutation Figure 2. p.A204T missense mutation in the CFTR gene.
X
ABCC7 p.Ala204Thr 19017867:98:227
status: NEW99 Left, A: the electrophoregram shows the wt and A204T DNA sequence analyses of exon 6a.
X
ABCC7 p.Ala204Thr 19017867:99:47
status: NEW105 Bottom right, C: Western blotting analysis of HeLa cells transiently expressing CFTR-wt, F508del, or A204T.
X
ABCC7 p.Ala204Thr 19017867:105:101
status: NEW